Coartem FDA Approval History
FDA Approved: Yes (First approved April 7, 2009)
Brand name: Coartem
Generic name: artemether and lumefantrine
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: Malaria
Coartem (artemether and lumefantrine) is an artemisinin-based combination treatment for the treatment of malaria.
Development timeline for Coartem
| Date | Article |
|---|---|
| Apr 8, 2009 | Approval Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.